NO333430B1 - Laktobacillus stammer, farmasoytisk sammensetning, sammensetning, absorberende produkt, meieriprodukt, kostholdsprodukt, funksjonell matvare omfattende nevnte stammer og anvendelse derav. - Google Patents
Laktobacillus stammer, farmasoytisk sammensetning, sammensetning, absorberende produkt, meieriprodukt, kostholdsprodukt, funksjonell matvare omfattende nevnte stammer og anvendelse derav. Download PDFInfo
- Publication number
- NO333430B1 NO333430B1 NO20044488A NO20044488A NO333430B1 NO 333430 B1 NO333430 B1 NO 333430B1 NO 20044488 A NO20044488 A NO 20044488A NO 20044488 A NO20044488 A NO 20044488A NO 333430 B1 NO333430 B1 NO 333430B1
- Authority
- NO
- Norway
- Prior art keywords
- lactobacillus
- strains
- strain
- composition according
- vaginal
- Prior art date
Links
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 108
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 70
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 28
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 16
- 235000013376 functional food Nutrition 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 title claims description 34
- 239000002250 absorbent Substances 0.000 title claims description 14
- 230000002745 absorbent Effects 0.000 title claims description 14
- 235000005911 diet Nutrition 0.000 title claims description 6
- 230000000378 dietary effect Effects 0.000 title claims description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 40
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 36
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 36
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 28
- 230000002265 prevention Effects 0.000 claims abstract description 28
- 208000018522 Gastrointestinal disease Diseases 0.000 claims abstract description 20
- 206010046914 Vaginal infection Diseases 0.000 claims abstract description 14
- 239000002417 nutraceutical Substances 0.000 claims abstract description 11
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 11
- 239000000758 substrate Substances 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 239000000832 lactitol Substances 0.000 claims description 16
- 235000010448 lactitol Nutrition 0.000 claims description 16
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical group OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 16
- 229960003451 lactitol Drugs 0.000 claims description 16
- 241000222122 Candida albicans Species 0.000 claims description 11
- 229940095731 candida albicans Drugs 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 11
- 208000019206 urinary tract infection Diseases 0.000 claims description 9
- 244000052616 bacterial pathogen Species 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 206010021639 Incontinence Diseases 0.000 claims description 6
- 239000000416 hydrocolloid Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 4
- 229960000511 lactulose Drugs 0.000 claims description 4
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 239000012487 rinsing solution Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000003232 mucoadhesive effect Effects 0.000 claims 2
- 239000006041 probiotic Substances 0.000 abstract description 55
- 235000018291 probiotics Nutrition 0.000 abstract description 55
- 240000006024 Lactobacillus plantarum Species 0.000 abstract description 12
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract description 11
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract description 11
- 235000013406 prebiotics Nutrition 0.000 abstract description 8
- 208000015181 infectious disease Diseases 0.000 abstract description 6
- 235000019722 synbiotics Nutrition 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 52
- 230000000529 probiotic effect Effects 0.000 description 52
- 241000894006 Bacteria Species 0.000 description 45
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 32
- 239000000047 product Substances 0.000 description 30
- 230000001580 bacterial effect Effects 0.000 description 28
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 27
- 210000002919 epithelial cell Anatomy 0.000 description 20
- 238000000338 in vitro Methods 0.000 description 20
- 238000011534 incubation Methods 0.000 description 17
- 239000004310 lactic acid Substances 0.000 description 16
- 235000014655 lactic acid Nutrition 0.000 description 16
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 13
- 208000037009 Vaginitis bacterial Diseases 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 11
- 238000009472 formulation Methods 0.000 description 9
- 230000000813 microbial effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 108010062877 Bacteriocins Proteins 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 244000199866 Lactobacillus casei Species 0.000 description 7
- 210000000941 bile Anatomy 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 235000013958 Lactobacillus casei Nutrition 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229940017800 lactobacillus casei Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 235000013618 yogurt Nutrition 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000011121 vaginal smear Methods 0.000 description 3
- 241000584079 Cubus Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 241000380806 Lactobacillus crispatus CTV-05 Species 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000020202 standardised milk Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000207202 Gardnerella Species 0.000 description 1
- 241000207201 Gardnerella vaginalis Species 0.000 description 1
- 206010017964 Gastrointestinal infection Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000025609 Urogenital disease Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000020603 homogenised milk Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36684702P | 2002-03-21 | 2002-03-21 | |
DKPA200200435 | 2002-03-21 | ||
PCT/DK2003/000195 WO2003080813A2 (en) | 2002-03-21 | 2003-03-21 | Lactobacillus strains |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20044488L NO20044488L (no) | 2004-12-20 |
NO333430B1 true NO333430B1 (no) | 2013-06-03 |
Family
ID=28455828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044488A NO333430B1 (no) | 2002-03-21 | 2004-10-20 | Laktobacillus stammer, farmasoytisk sammensetning, sammensetning, absorberende produkt, meieriprodukt, kostholdsprodukt, funksjonell matvare omfattende nevnte stammer og anvendelse derav. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8460917B2 (es) |
EP (1) | EP1485463B1 (es) |
AT (1) | ATE409220T1 (es) |
AU (1) | AU2003215526B2 (es) |
DE (1) | DE60323734D1 (es) |
DK (1) | DK1485463T3 (es) |
ES (1) | ES2311718T3 (es) |
NO (1) | NO333430B1 (es) |
PL (1) | PL212647B1 (es) |
PT (1) | PT1485463E (es) |
RU (1) | RU2316586C2 (es) |
SI (1) | SI1485463T1 (es) |
WO (1) | WO2003080813A2 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2237732T3 (es) | 2003-11-03 | 2005-08-01 | Peter-Hansen Volkmann | Composicion para el cuidado vaginal. |
GB0330009D0 (en) | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
JP2008517015A (ja) * | 2004-10-22 | 2008-05-22 | メディノバ アクチェンゲゼルシャフト | 胃腸病原菌に対して有用な乳酸菌、及び当該乳酸菌を含む組成物 |
WO2006045347A1 (en) | 2004-10-22 | 2006-05-04 | Medinova Ag | Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens |
EP1736537A1 (en) * | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
US10953051B2 (en) | 2005-06-22 | 2021-03-23 | Novozymes A/S | Methods and means for protecting the skin against pathogenic microorganisms |
EE05341B1 (et) * | 2008-05-13 | 2010-08-16 | O� Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek |
ITMI20080949A1 (it) * | 2008-05-22 | 2009-11-23 | Sinclair Pharma Srl | Nuovo ceppo del genere lactobacillus e formulazioni farmaceutiche topiche che lo contengono |
FI20095550A0 (fi) * | 2009-05-19 | 2009-05-19 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
EP3260126A1 (en) * | 2009-10-09 | 2017-12-27 | Prothera, Inc. | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
US8372392B2 (en) * | 2009-12-23 | 2013-02-12 | Lytone Enterprise, Inc. | Lactobacillus paracasei strain LT12 as immunity regulatory agent |
GB2482536B (en) | 2010-08-05 | 2013-07-24 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
RU2465322C2 (ru) * | 2010-12-09 | 2012-10-27 | Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) | ШТАММ БАКТЕРИЙ Lactobacillus casei/paracasei - ВГНКИ 10.02.62 ДЕП, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРИГОТОВЛЕНИЯ ПРОБИОТИЧЕСКОЙ ДОБАВКИ |
EE05750B1 (et) * | 2011-02-25 | 2015-06-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine |
RU2453594C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus paracasei, используемый для получения продукции, содержащей лактобактерии |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
RU2461617C1 (ru) * | 2011-09-05 | 2012-09-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм lactobacillus paracasei, используемый для производства кисломолочных напитков |
ITRM20110475A1 (it) * | 2011-09-09 | 2013-03-10 | Probiotical Spa | Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e |
EP2596797B1 (en) * | 2011-11-23 | 2015-10-21 | Biolatte Oy | A vaginal capsule |
WO2013113767A1 (en) | 2012-01-31 | 2013-08-08 | Bioclin Bv | Method for administration of a probiotic |
RU2482177C1 (ru) * | 2012-02-16 | 2013-05-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации"(ГБОУ ВПО Тверская ГМА Минздрава России) | ШТАММ БАКТЕРИЙ Lactobacillus plantarum, ОБЛАДАЮЩИЙ ШИРОКИМ СПЕКТРОМ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТИ ПО ОТНОШЕНИЮ К ПАТОГЕННЫМ И УСЛОВНО-ПАТОГЕННЫМ МИКРООРГАНИЗМАМ |
ITMI20130793A1 (it) | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
RU2567149C1 (ru) * | 2014-12-24 | 2015-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ Lactobacillus plantarum, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ И ПРОБИОТИЧЕСКИХ ПРЕПАРАТОВ |
KR20170032815A (ko) | 2015-09-15 | 2017-03-23 | 경희대학교 산학협력단 | 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물 |
KR102587444B1 (ko) | 2015-09-29 | 2023-10-11 | 킴벌리-클라크 월드와이드, 인크. | 미생물총의 건강한 균형을 유지하기 위한 상승 조성물 |
PL232671B1 (pl) * | 2016-04-13 | 2019-07-31 | Lactopharm Spolka Z Ograniczona Odpowiedzialnoscia | Nowy szczep Lactobacillus plantarum AMT12 i kompozycja zawierająca szczep Lactobacillus plantarum AMT12 |
EP3454873B1 (en) * | 2016-05-09 | 2022-11-02 | ADM Denmark A/S | Probiotic composition and uses thereof |
IT201700030619A1 (it) * | 2017-03-20 | 2018-09-20 | Labomar S R L | Composizioni topiche vaginali. |
DE102017113263A1 (de) * | 2017-06-16 | 2018-12-20 | Lactopia GmbH | Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke |
EP3556226B1 (de) * | 2018-04-20 | 2021-01-20 | Raab Vitalfood GmbH | Komplex-synbiotikum zum aufbau einer gesunden darmflora |
KR101930438B1 (ko) * | 2018-10-12 | 2018-12-18 | (주) 에이투젠 | 신규한 락토바실러스 플란타룸 균주 atg-k2, atg-k6 또는 atg-k8, 이를 포함하는 질염의 예방 또는 치료용 조성물 |
IT201800020425A1 (it) * | 2018-12-20 | 2020-06-20 | Univ Degli Studi Di Modena E Reggio Emilia | Lattobacilli con attività antimicrobica |
JP2023532085A (ja) * | 2020-06-30 | 2023-07-26 | ビレオ システムズ インコーポレイテッド | 膣感染症を治療するための組成物及び方法 |
WO2022187678A1 (en) * | 2021-03-04 | 2022-09-09 | Duke University | Compositions and methods for the diagnosis and treatment of alzheimer's disease or other neurodegenerative disorders |
CN114591875B (zh) * | 2022-05-07 | 2022-07-29 | 微康益生菌(苏州)股份有限公司 | 一种改善阴道环境的嗜酸乳杆菌la88及其培养方法与应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211769A (en) * | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
US5804179A (en) | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
SE9100364L (sv) * | 1991-02-05 | 1992-08-06 | Bac Dev In Sweden Ab | Tampong eller binda impregnerad med en kultur av levande mjoelksyrabakterier i avsikt att minska risken foer urogenitala infektioner |
GB2261372A (en) | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
UA39965C2 (uk) * | 1993-12-03 | 2001-07-16 | Лайфор Леборетріз Лтд | Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти ) |
CN1094972C (zh) | 1994-05-26 | 2002-11-27 | 伯拉考公司 | 人类来源的乳酸杆菌菌株、它们的组合物及其应用 |
JPH11504048A (ja) | 1996-02-14 | 1999-04-06 | ザ、プロクター、エンド、ギャンブル、カンパニー | 泌尿生殖器および腸用の組成物 |
AU5113798A (en) | 1996-11-29 | 1998-06-22 | Bio K & International Inc. | Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof |
US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
SE510813C2 (sv) | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen |
SE519648C2 (sv) | 1998-03-06 | 2003-03-25 | Essum Ab | Ny stam av Lactobacillus plantarum |
DK0956858T3 (da) | 1998-04-30 | 2002-01-28 | Vesely Renata Maria Cavaliere | Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner |
EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
EP1034788A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
US20020044926A1 (en) | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
-
2003
- 2003-03-21 ES ES03744768T patent/ES2311718T3/es not_active Expired - Lifetime
- 2003-03-21 PL PL372587A patent/PL212647B1/pl unknown
- 2003-03-21 US US10/508,324 patent/US8460917B2/en active Active
- 2003-03-21 RU RU2004130876/13A patent/RU2316586C2/ru active
- 2003-03-21 AU AU2003215526A patent/AU2003215526B2/en not_active Expired
- 2003-03-21 PT PT03744768T patent/PT1485463E/pt unknown
- 2003-03-21 SI SI200331462T patent/SI1485463T1/sl unknown
- 2003-03-21 WO PCT/DK2003/000195 patent/WO2003080813A2/en active IP Right Grant
- 2003-03-21 DE DE60323734T patent/DE60323734D1/de not_active Expired - Lifetime
- 2003-03-21 DK DK03744768T patent/DK1485463T3/da active
- 2003-03-21 AT AT03744768T patent/ATE409220T1/de active
- 2003-03-21 EP EP03744768A patent/EP1485463B1/en not_active Expired - Lifetime
-
2004
- 2004-10-20 NO NO20044488A patent/NO333430B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003215526B2 (en) | 2008-01-17 |
PT1485463E (pt) | 2008-12-30 |
AU2003215526A1 (en) | 2003-10-08 |
DE60323734D1 (de) | 2008-11-06 |
SI1485463T1 (sl) | 2009-02-28 |
RU2004130876A (ru) | 2005-04-10 |
US8460917B2 (en) | 2013-06-11 |
US20050220776A1 (en) | 2005-10-06 |
RU2316586C2 (ru) | 2008-02-10 |
ATE409220T1 (de) | 2008-10-15 |
PL372587A1 (en) | 2005-07-25 |
WO2003080813A3 (en) | 2003-12-24 |
PL212647B1 (pl) | 2012-11-30 |
ES2311718T3 (es) | 2009-02-16 |
NO20044488L (no) | 2004-12-20 |
DK1485463T3 (da) | 2008-11-10 |
EP1485463A2 (en) | 2004-12-15 |
WO2003080813A2 (en) | 2003-10-02 |
EP1485463B1 (en) | 2008-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO333430B1 (no) | Laktobacillus stammer, farmasoytisk sammensetning, sammensetning, absorberende produkt, meieriprodukt, kostholdsprodukt, funksjonell matvare omfattende nevnte stammer og anvendelse derav. | |
JP5147402B2 (ja) | 膣健康改善のためのプロバイオティックラクトバチルス株 | |
JP4455333B2 (ja) | プロバイオティック細菌:Lactobacillusfermentum | |
SK280681B6 (sk) | Kmeň baktérií lactobacillus acidophilus, prostried | |
NO327205B1 (no) | Lactobacillus paracasei-stamme, sammensetning inneholdende en slik stamme samt anvendelser derav. | |
US20080131462A1 (en) | Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same | |
JP7126004B2 (ja) | 組成物及びその使用 | |
TW201534313A (zh) | 作為益生菌之乳桿菌屬菌株 | |
KR100993562B1 (ko) | 락토바실러스 균주 | |
US20240066078A1 (en) | Strains, compositions and methods of use | |
EP2742125B1 (en) | New strain of l. bulgaricus capable of inhibiting the adhesion of h. pylori strains to epithelial cells | |
RU2641258C1 (ru) | Пробиотический штамм Lactobacillus gasseri и его композиция с лактоферрином для профилактики диареи, некротизирующего энтероколита и сепсиса, вызываемых штаммами Escherichia coli у преждевременно рожденных детей | |
CN117165497B (zh) | 一种改善便秘的植物乳植杆菌Lp18及其应用和产品 | |
BG112471A (bg) | Имуномодулиращ синбиотичен състав | |
US20240050493A1 (en) | Strains, compositions and methods of use | |
CN116801893A (zh) | 菌株、组合物和使用方法 | |
Li et al. | Change of Lactobacillus and Bifidobacteria genera from breast milk to elders and their potential for preserving human health | |
CN117062614A (zh) | 菌株、组合物和使用方法 | |
BG2759U1 (bg) | Имуномодулиращ синбиотичен състав |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |